Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
ARIAD Pharmaceuticals
Scientific Title
A Phase 3 Multicenter Open-label Study of Brigatinib (AP26113) Versus Crizotinib in Patients With ALK-positive Advanced Lung Cancer